Biotech · Private company
PRA Health Sciences
Track this companyFree. Adds PRA Health Sciences to your Dealase workspace and tells you when its record changes.
Clinical trials251 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials25
- Evaluation of the Efficacy, Safety, and Tolerability of LevoCeptPHASE3 · NOT_YET_RECRUITING · started Jun 1, 2026ClinicalTrials.gov NCT04457076 · fetched Nov 12, 2026
- Evaluation of Oral PF614 Relative to OxyContin (PF614-102)PHASE1 · COMPLETED · started Sep 8, 2021ClinicalTrials.gov NCT05043766 · fetched Nov 12, 2026
- Randomized Study of Extended Treatment With Firibastat in Treatment-Resistant Hypertension (REFRESH)PHASE3 · TERMINATED · started Aug 5, 2021ClinicalTrials.gov NCT04857840 · fetched Nov 12, 2026
- Real-world Effectiveness and Cardiovascular Safety Study of Abaloparatide in Postmenopausal WomenCOMPLETED · started Jul 1, 2021ClinicalTrials.gov NCT04974723 · fetched Nov 12, 2026
- Drug-Drug Interaction Study Between EDP-514, Itraconazole, Carbamazepine, and Quinidine in Healthy SubjectsPHASE1 · COMPLETED · started Nov 5, 2020ClinicalTrials.gov NCT04783753 · fetched Nov 12, 2026
- Bioavailability and Food Effect Study of 3 Types of CarisbamatePHASE1 · COMPLETED · started Aug 27, 2020ClinicalTrials.gov NCT04520360 · fetched Nov 12, 2026
- A Clinical Study of Melphalan Flufenamide (Melflufen) and Dexamethasone for Patients With Immunoglobulin Light Chain (AL) AmyloidosisPHASE1 · TERMINATED · started Aug 6, 2020ClinicalTrials.gov NCT04115956 · fetched Nov 12, 2026
- Single Dose Crossover Study to Compare the Respiratory Drive After Administration of Belbuca, Oxycodone and Placebo.PHASE1 · COMPLETED · started Jul 23, 2019ClinicalTrials.gov NCT03996694 · fetched Nov 12, 2026
- A Single and Multiple Ascending Dose Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of KP-1199PHASE1 · TERMINATED · started Mar 12, 2019ClinicalTrials.gov NCT03880487 · fetched Nov 12, 2026
- A Trial of Single- and Multiple-doses of Aripiprazole in Adult Subjects With Schizophrenia or Bipolar I DisorderPHASE1 · COMPLETED · started Jan 31, 2019ClinicalTrials.gov NCT03854409 · fetched Nov 12, 2026
- Open- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate CancerPHASE3 · COMPLETED · started Oct 18, 2018ClinicalTrials.gov NCT03686683 · fetched Nov 12, 2026
- Pre-Symptomatic Study of Intravenous Onasemnogene Abeparvovec-xioi in Spinal Muscular Atrophy (SMA) for Patients With Multiple Copies of SMN2PHASE3 · COMPLETED · started Apr 2, 2018ClinicalTrials.gov NCT03505099 · fetched Nov 12, 2026
- A Study of LJPC-401 for the Treatment of Iron Overload in Adult Patients With Hereditary HemochromatosisPHASE2 · COMPLETED · started Nov 29, 2017ClinicalTrials.gov NCT03395704 · fetched Nov 12, 2026
- Study of PF614 Compared to OxyContin® in Healthy Volunteers (PF614-101)PHASE1 · COMPLETED · started Nov 16, 2016ClinicalTrials.gov NCT02454712 · fetched Nov 12, 2026
- Long Term Safety of Anifrolumab in Adult Subjects With Active Systemic Lupus ErythematosusPHASE3 · COMPLETED · started Jun 30, 2016ClinicalTrials.gov NCT02794285 · fetched Nov 12, 2026
- Study to Evaluate Safety and Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Aged 10-24 YearsPHASE3 · COMPLETED · started Jun 22, 2016ClinicalTrials.gov NCT02725593 · fetched Nov 12, 2026
- A Double-blind Study of Paclitaxel in Combination With Reparixin or Placebo for Metastatic Triple-Negative Breast CancerPHASE2 · COMPLETED · started Jul 29, 2015ClinicalTrials.gov NCT02370238 · fetched Nov 12, 2026
- Efficacy and Safety of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus ErythematosusPHASE3 · COMPLETED · started Jul 9, 2015ClinicalTrials.gov NCT02446899 · fetched Nov 12, 2026
- Efficacy and Safety of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus ErythematosusPHASE3 · COMPLETED · started Jun 9, 2015ClinicalTrials.gov NCT02446912 · fetched Nov 12, 2026
- Phase II Study of MEDI4736, Tremelimumab, and MEDI4736 in Combination w/ Tremelimumab Squamous Cell Carcinoma of the Head and NeckPHASE2 · COMPLETED · started Apr 15, 2015ClinicalTrials.gov NCT02319044 · fetched Nov 12, 2026
- Phase II Study of MEDI4736 Monotherapy in Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckPHASE2 · COMPLETED · started Oct 23, 2014ClinicalTrials.gov NCT02207530 · fetched Nov 12, 2026
- Pediatric Arthritis Study of Certolizumab PegolPHASE3 · COMPLETED · started Mar 8, 2012ClinicalTrials.gov NCT01550003 · fetched Nov 12, 2026
- Pilot Study to Evaluate Reparixin With Weekly Paclitaxel in Patients With HER 2 Negative Metastatic Breast Cancer (MBC)PHASE1 · COMPLETED · started Feb 27, 2012ClinicalTrials.gov NCT02001974 · fetched Nov 12, 2026
- Study of the Safety and Efficacy of TH-302 in Combination With Gemcitabine Compared With Gemcitabine Alone in Previously Untreated Patients With Pancreatic AdenocarcinomaPHASE2 · COMPLETED · started Jun 1, 2010ClinicalTrials.gov NCT01144455 · fetched Nov 12, 2026
- Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain InjuryPHASE3 · COMPLETED · started Jun 1, 2010ClinicalTrials.gov NCT01143064 · fetched Nov 12, 2026